Hit Enter to search or Esc to close
0
Safinamide

Safinamide

CAS NO.:133865-89-1
MF:C17H19FN2O2
EINECS NO.:603-772-2
API161
Quantity
Send Inquiry
add to cart

Product Name
Safinamide
Appearance
White powder
Specification
 99%
Test Method
HPLC
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
Under inert gas (nitrogen or Argon) at 2–8 °C
Shelf Time
24 months
  SolubilitySoluble in DMSO (up to 50mg/ml).
   Acidity
  coefficient(pKa)
16.03±0.50(Predicted)

Safinamide is a MAO-B inhibitor used as an add-on treatment to levodopa/carbidopa for Parkinson's disease during"off"episodes.
It was approved in Europe in February 2015, and in the United States on March 21, 2017.on.

Safinamide is indicated as an add-on treatment to levodopa with or without other medicines for Parkinson’s disease